Breast tenderness during hormone replacement therapy linked to elevated cancer risk

Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.

Read the whole article on Physorg

More from Physorg